LIXT is developing LB-100, a first-in-class therapy designed to enhance the effectiveness of established cancer treatments while cutting down toxicity…
On Tuesday this week, researchers revealed that a group of hackers linked to the Iranian government had targeted another United States medical institution…
ETST is focused on compounding pharmacies, telemedicine, and clinical services Vertically integrated model supports recurring, patient-driven revenue The company’s strategy…
The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate AI-based ECG Algorithms The collaboration…
For a long time, scientists have been working tirelessly to come up with vaccines against cancer. Significant progress is being registered in developing mRNA vaccines against…
A landmark Phase III trial published in The Lancet demonstrated a five-year overall survival rate of 90.9% for oropharyngeal cancer…
Soligenix is entering a pivotal period marked by several anticipated clinical readouts and milestones expected throughout 2026. At the heart…
Designations granted by leading global regulatory agencies play a critical role in advancing drug-development programs. The UK Medicines and Healthcare…
Enormous resources are being channeled into studying different ways to support the immune system in its fight against cancer. One emerging approach is…
Recent research shows how chemotherapy and immunotherapy can complement each other when used together. Within this evolving scientific landscape, LIXTE…